{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:17:43Z","timestamp":1788369463338,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Urol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early detection of clinically significant prostate cancer (csPCa) remains a major challenge in urologic oncology. Although prostate-specific antigen (PSA) screening and systematic transrectal ultrasound\u2013 guided biopsy has historically been the main diagnostic approaches, these strategies are associated with both overdiagnosis of indolent disease and underdetection of clinically significant tumors. Recent advances in imaging technologies\u2014including multiparametric magnetic resonance imaging (mpMRI), high-resolution micro-ultrasound (MUS), and prostate-specific membrane antigen positron emission tomography (PSMA PET)\u2014have significantly improved the diagnostic pathway for prostate cancer. In parallel, artificial intelligence (AI)\u2013based algorithms have emerged as promising tools for enhancing image interpretation and reducing diagnostic variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This review aims to summarize current evidence regarding the diagnostic performance of micro- ultrasound, mpMRI, and PSMA PET in prostate cancer detection and to explore the potential role of artificial intelligence in integrating these imaging modalities to improve diagnostic accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic literature search was performed using PubMed and MEDLINE databases for articles published between January 2013 and December 2024. The following search strategy was employed using combinations of MeSH terms and keywords: (\u2018prostate cancer\u2019 OR \u2018prostate neoplasm\u2019 OR \u2018prostatic carcinoma\u2019) AND (\u2018micro-ultrasound\u2019 OR \u2018high-resolution micro-ultrasound\u2019 OR \u2018micro-US\u2019 OR \u2018PRI-MUS\u2019 OR \u2018ExactVu\u2019) OR (\u2018multiparametric MRI\u2019 OR \u2018mpMRI\u2019 OR \u2018multi-parametric magnetic resonance imaging\u2019 OR \u2018PI-RADS\u2019) OR (\u2018PSMA PET\u2019 OR \u2018prostate-specific membrane antigen\u2019 OR \u201868Ga-PSMA\u2019 OR \u201818F-DCFPyL\u2019 OR \u2018PSMA-11\u2019) OR (\u2018artificial intelligence\u2019 OR \u2018machine learning\u2019 OR \u2018deep learning\u2019 OR \u2018radiomics\u2019 OR \u2018neural network\u2019). Only English-language, peer-reviewed original research articles, systematic reviews, meta-analyses, and major consensus guidelines were included. Case reports, editorials, conference abstracts, and non-peer-reviewed publications were excluded. Two authors (A.R. and O.Z.) independently screened titles and abstracts for relevance. Full texts of potentially eligible articles were retrieved and assessed against predefined inclusion criteria: (1) evaluation of mpMRI, micro-ultrasound, or PSMA PET for prostate cancer detection, localization, or staging; (2) reported diagnostic accuracy metrics (sensitivity, specificity, AUC) or biopsy outcomes; (3) sample size \u226520 patients for original studies. Disagreements were resolved by consensus with a third author (M.B.). Reference lists of included articles were hand-searched for additional relevant studies. A narrative synthesis was conducted due to heterogeneity in study designs, populations, and outcome measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Multiparametric MRI has become a cornerstone in prostate cancer diagnosis due to its high sensitivity for detecting clinically significant diseases and its role in guiding targeted biopsies. Micro-ultrasound, offering substantially higher spatial resolution than conventional ultrasound, has demonstrated promising diagnostic performance and may represent a cost-effective alternative or complement to in review mpMRI. Meanwhile, PSMA PET imaging has shown high sensitivity for identifying both intraprostatic lesions and metastatic disease. Emerging evidence suggests that combining these imaging modalities may significantly enhance detection rates. Furthermore, artificial intelligence techniques\u2014including machine learning and deep learning algorithms\u2014have shown potential in improving lesion detection, segmentation, and risk stratification in prostate imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The integration of multimodal imaging approaches with artificial intelligence represents a promising investigational strategy that may, following prospective validation, improve prostate cancer detection and characterization. Future prospective studies are needed to validate these technologies and define their optimal role in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fruro.2026.1829407","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:46:40Z","timestamp":1780030000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Next-generation imaging in prostate cancer"],"prefix":"10.3389","volume":"6","author":[{"given":"Ahmed","family":"Rabie","sequence":"first","affiliation":[{"name":"Urology, Northwell Health","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Buscarini","sequence":"additional","affiliation":[{"name":"Urology, Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Zaytoun","sequence":"additional","affiliation":[{"name":"Urology, Mount Sinai","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging\u2013reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-025-02140-6","article-title":"Navigating discordant findings in multimodality imaging of prostate cancer in the MRI and PSMA-PET era","volume":"131","author":"Woo","year":"2026","journal-title":"La Radiologia Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041280","article-title":"Micro-ultrasound: current role in prostate cancer diagnosis and future possibilities","volume":"15","author":"Basso Dias","year":"2023","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s1569-9056(19)34483-5","article-title":"Comparison of micro-ultrasound and multiparametric MRI imaging for prostate cancer: A multicentre prospective analysis","volume":"18","author":"Lughezzani","year":"2019","journal-title":"Eur Urol Suppl"},{"key":"B11","article-title":"Prostate-specific membrane antigen expression in normal and Malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2018.19.5.819","article-title":"Prostate-specific membrane antigen PET imaging in prostate cancer: opportunities and challenges","volume":"19","author":"Oh","year":"2018","journal-title":"Korean J Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210563","article-title":"Deep learning-based artificial intelligence applications in prostate MRI: brief summary","volume":"95","author":"Turkbey","year":"2022","journal-title":"Br J Radiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radio"},{"key":"B17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/radiol.09090475","article-title":"Prostate cancer: value of multiparametric MR imaging at 3 T for detection\u2014histopathologifc correlation","volume":"255","author":"Turkbey","year":"2010","journal-title":"Radiology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2014.10.026","article-title":"Detection of clinically significant prostate cancer using magnetic resonance imaging\u2013ultrasound fusion targeted biopsy: a systematic review","volume":"68","author":"Valerio","year":"2015","journal-title":"Eur Urol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists","volume":"280","author":"Rosenkrantz","year":"2016","journal-title":"Radiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.juro.2012.08.095","article-title":"Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device","volume":"189","author":"Sonn","year":"2013","journal-title":"J Urol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"E70","DOI":"10.5489\/cuaj.5361","article-title":"Comparison of conventional transrectal ultrasound, magnetic resonance imaging, and micro-ultrasound for visualizing prostate cancer in an active surveillance population: a feasibility study","volume":"13","author":"Eure","year":"2018","journal-title":"Can Urol Assoc J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.06.022","article-title":"Evolution of targeted prostate biopsy by adding micro-ultrasound to the magnetic resonance imaging pathway","volume":"7","author":"Wiemer","year":"2021","journal-title":"Eur Urol Focus"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s1569-9056(16)30358-x","article-title":"Micro-ultrasound of the prostate, PRI-MUS\u2122 protocol guidance along with clinical variables: Combined approach for reducing unnecessary biopsies","volume":"12","author":"Wodlinger","year":"2016","journal-title":"Eur Urol Suppl"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-023-04521-w","article-title":"The diagnostic accuracy of micro-ultrasound for prostate cancer diagnosis: a review","volume":"41","author":"Avolio","year":"2023","journal-title":"World J Urol"},{"key":"B25","article-title":"Prostate-specific membrane antigen expression in normal and Malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2018170108","article-title":"Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls","volume":"38","author":"Hofman","year":"2018","journal-title":"Radiographics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.053","article-title":"Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer","volume":"70","author":"Eiber","year":"2016","journal-title":"Eur Urol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.12.025","article-title":"Diagnostic efficacy of 68gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer","volume":"195","author":"Maurer","year":"2016","journal-title":"J Urol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219501","article-title":"Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology","volume":"60","author":"Hope","year":"2019","journal-title":"J Nucl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18020234","article-title":"PSMA-based radiopharmaceuticals in prostate cancer theranostics: imaging, clinical advances, and future directions","volume":"18","author":"Civelek","year":"2026","journal-title":"Cancers"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0016-5","article-title":"Artificial intelligence in radiology","volume":"18","author":"Hosny","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30739-9","article-title":"Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study","volume":"21","author":"Bulten","year":"2020","journal-title":"Lancet Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1117\/12.2512547","article-title":"Automated prostate segmentation of volumetric CT images using 3D deeply supervised dilated FCN","volume":"10949","author":"Wang","year":"2019","journal-title":"Med Imaging 2019: Image Process"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030486","article-title":"A systematic review on artificial intelligence evaluating metastatic prostatic cancer and lymph nodes on PSMA PET scans","volume":"16","author":"Liu","year":"2024","journal-title":"Cancers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210563","article-title":"Deep learning-based artificial intelligence applications in prostate MRI: brief summary","volume":"95","author":"Turkbey","year":"2022","journal-title":"Br J Radiol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.13.11046","article-title":"Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis","volume":"202","author":"De Rooij","year":"2014","journal-title":"Am J Roentgenology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.07.002","article-title":"Systematic review of cost-effectiveness models in prostate cancer: exploring new developments in testing and diagnosis","volume":"25","author":"Keeney","year":"2022","journal-title":"Value Health"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Frontiers in Urology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2026.1829407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:46:45Z","timestamp":1780030005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fruro.2026.1829407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":39,"alternative-id":["10.3389\/fruro.2026.1829407"],"URL":"https:\/\/doi.org\/10.3389\/fruro.2026.1829407","relation":{},"ISSN":["2673-9828"],"issn-type":[{"value":"2673-9828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1829407"}}